Instil Bio Inc (TIL) Stock Analysis
Verdict: AVOID
Severe cash burn and debt overload leave Instil Bio with critical dilution risk, making short-term capital loss highly likely.
Investment score: 20/100
Analysis as of
Is Instil Bio Inc stock worth reviewing? AI model thesis
The AI model recommends avoiding Instil Bio Inc due to extreme dilution risk driven by a 2.2-month cash runway ($6.64M cash vs -$36.62M annual FCF burn), $85.18M in total debt, zero revenue, and Wall Street downgrades.
7-factor investment score
- Valuation: 15/100 (weight 20%)
- Financial Health: 10/100 (weight 15%)
- Technical Momentum: 25/100 (weight 15%)
- Earnings Quality: 20/100 (weight 15%)
- Insider Sentiment: 40/100 (weight 10%)
- Analyst Consensus: 20/100 (weight 10%)
- Risk-Adjusted Return: 15/100 (weight 15%)
Instil Bio Inc opportunities and risks
What speaks for TIL
- Pipeline In-Licensing Catalyst
What speaks against TIL
- Imminent Dilutive Financing
Frequently asked questions about Instil Bio Inc (TIL)
Is TIL stock a good investment?
The cached TradeMates AI model rates Instil Bio Inc as AVOID with an investment score of 20/100. The AI model recommends avoiding Instil Bio Inc due to extreme dilution risk driven by a 2.2-month cash runway ($6.64M cash vs -$36.62M annual FCF burn), $85.18M in total debt, zero revenue, and Wall Street downgrades. This is algorithmic model output, not personal investment advice.
Is TIL stock a buy?
The TradeMates model verdict for TIL is AVOID with an investment score of 20/100. Treat this as a model signal to review, not a personal buy recommendation.